Epidemiology and Treatment Trends in the Management of Dupuytren's Disease From 2016 to 2022.
Pineda N, Ghayyad K, Beaudoin TF, Hirsch D, Fathi M, Zeini I, Kachooei AR.
Pineda N, et al.
Cureus. 2024 Oct 28;16(10):e72528. doi: 10.7759/cureus.72528. eCollection 2024 Oct.
Cureus. 2024.
PMID: 39606527
Free PMC article.
Dupuytren disease was more prevalent in males (M/F ratio of 1.5/1) and White patients. Notable comorbidities included diabetes in 25% of patients, smoking history in 11% of patients, and hypothyroidism in 17% of patients. ...
Dupuytren disease was more prevalent in males (M/F ratio of 1.5/1) and White patients. Notable comorbidities included diabetes in 25% …